Safranski et al., 1992 - Google Patents
Use of melengestrol acetate and gonadotropins to induce fertile estrus in seasonally anestrous ewesSafranski et al., 1992
View PDF- Document ID
- 13056203949520789969
- Author
- Safranski T
- Lamberson W
- Keisler D
- Publication year
- Publication venue
- Journal of animal science
External Links
Snippet
Ewes of three genotypes (Hampshire, n= 59; Rambouillet, n= 36; crossbred, n= 57) were used to determine the efficiency of melengestrol acetate (MGA) and (or) PG-600 (a combination of pregnant mare's serum gonadotropin and human chorionic gonadotropin) in …
- 229960003846 Melengestrol Acetate 0 title abstract description 70
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Safranski et al. | Use of melengestrol acetate and gonadotropins to induce fertile estrus in seasonally anestrous ewes | |
| Kaim et al. | Effects of GnRH administered to cows at the onset of estrus on timing of ovulation, endocrine responses, and conception | |
| Barbieri et al. | Danazol inhibits steroidogenesis | |
| Armstrong et al. | Endocrine responses of goats after induction of superovulation with PMSG and FSH | |
| Younis et al. | Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization–embryo transfer cycles with a long gonadotropin-releasing hormone agonist | |
| Fike et al. | Estrus and luteal function in suckled beef cows that were anestrous when treated with an intravaginal device containing progesterone with or without a subsequent injection of estradiol benzoate | |
| Cavalieri et al. | Synchronization of estrus and ovulation and associated endocrine changes in Bos indicus cows | |
| Balen | Hypersecretion of luteinizing hormone and the polycystic ovary syndrome | |
| Nett et al. | Pituitary receptors for GnRH and estradiol, and pituitary content of gonadotropins in beef cows. II. Changes during the postpartum period | |
| Abecia et al. | The effect of melatonin treatment on the ovarian response of ewes to the ram effect | |
| Mizumachi et al. | Superovulation of ewes immunized against the human recombinant inhibin αSubunit associated with increased pre-and postovulatory follicle-stimulating hormone levels | |
| LEGAN et al. | Importance of short luteal phases in the endocrine mechanism controlling initiation of estrous cycles in anestrous ewes | |
| Duffy et al. | The effect of eCG or estradiol at or after norgestomet removal on follicular dynamics, estrus and ovulation in early post-partum beef cows nursing calves | |
| TURGEON et al. | Acute progesterone and 17β-estradiol modulation of luteinizing hormone secretion by pituitaries of cycling rats superfused in vitro | |
| Warnock et al. | Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy | |
| Ory et al. | Ovulation induction with pulsatile gonadotropin-releasing hormone administration in patients with polycystic ovarian syndrome | |
| Advis et al. | Direct hypothalamic control of vasoactive intestinal peptide (VIP) levels in the developing rat ovary | |
| Tummon et al. | A randomized, prospective comparison of endocrine changes induced with intranasal leuprolide or danazol for treatment of endometriosis | |
| Doughty et al. | Hormonal control of sexual differentiation of the hypothalamus in the neonatal female rat | |
| Bloch et al. | Prepubertal testosterone treatment of female rats: defeminization of behavioral and endocrine function in adulthood | |
| Knights et al. | Ability of ram introduction to induce LH secretion, estrus and ovulation in fall-born ewe lambs during anestrus | |
| Lane et al. | The effect of estradiol benzoate or a synthetic gonadotropin-releasing hormone used at the start of a progesterone treatment on estrous response in cattle | |
| Bider et al. | Endocrinology: The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization—a randomized study | |
| Yuen et al. | Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility | |
| Handler et al. | Influence of reproductive stage at PRID™ insertion on synchronization of estrus and ovulation in mares |